3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2/3
1
Status
Unknown
2
Terminated
2
Active not recruiting
2
Withdrawn
1
Recruiting
1
Completed
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Conditions
Ovarian Neoplasms
406
Uterine Cervical Neoplasms
400
Endometrial Neoplasms
197
Carcinoma, Ovarian Epithelial
100
Breast Neoplasms
72
Fallopian Tube Neoplasms
71
Uterine Cervical Dysplasia
68
Neoplasms
51
Colorectal Neoplasms
42
Pancreatic Neoplasms
40
Stomach Neoplasms
39
Peritoneal Neoplasms
32
Papillomavirus Infections
32
Recurrence
31
Uterine Neoplasms
29
Vulvar Neoplasms
27
Prostatic Neoplasms
26
Lung Neoplasms
24
Esophageal Neoplasms
23
Urinary Bladder Neoplasms
22
Melanoma
20
Colonic Neoplasms
20
Head and Neck Neoplasms
19
Gynecologic Cancer
19
Endometrial Hyperplasia
18
Neoplasm Metastasis
17
Carcinoma, Non-Small-Cell Lung
17
Squamous Intraepithelial Lesions
16
Sarcoma
16
Ovarian Cysts
15
Interventions
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Cystadenocarcinoma, Serous
×
Gynecologic
×
Clear all
NCT03150121
2020-02-26
BEDOCA
Sheba Medical Center
Phase NA
Unknown
500 enrolled
NCT04055038
2019-08-13
EPITOC
Blokhin's Russian Cancer Research Center
Phase 2/3
Unknown
164 enrolled